COEGIN — Coegin Pharma AB Balance Sheet
0.000.00%
- SEK180.11m
- SEK167.78m
Annual balance sheet for Coegin Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | Interim Report | ARS | ARS | ARS |
| Standards: | SAS | — | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 16.6 | 25.7 | 3.82 | 5.55 | 19.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.35 | 4.5 | 2.75 | 0.499 | 0.989 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 19.1 | 30.3 | 6.97 | 6.21 | 20.8 |
| Net Property, Plant And Equipment | 0.002 | 0.002 | 0.485 | 0.302 | 0.148 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 19.1 | 30.3 | 29.2 | 15.4 | 27 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.43 | 10.3 | 8.23 | 8.68 | 1.78 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 2.43 | 10.3 | 8.23 | 8.68 | 1.78 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 16.7 | 20.1 | 21 | 6.75 | 25.3 |
| Total Liabilities & Shareholders' Equity | 19.1 | 30.3 | 29.2 | 15.4 | 27 |
| Total Common Shares Outstanding |